X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs DR. DATSONS LABS - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH DR. DATSONS LABS STERLING BIOTECH/
DR. DATSONS LABS
 
P/E (TTM) x -0.4 -10.9 - View Chart
P/BV x 0.0 0.2 8.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   DR. DATSONS LABS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
DR. DATSONS LABS
Mar-14
STERLING BIOTECH/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs11126 8.4%   
Low Rs331 11.0%   
Sales per share (Unadj.) Rs26.8133.0 20.2%  
Earnings per share (Unadj.) Rs-15.00.2 -9,865.3%  
Cash flow per share (Unadj.) Rs-5.56.6 -82.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9128.8 42.6%  
Shares outstanding (eoy) m267.8731.66 846.1%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x0.30.6 44.1%   
Avg P/E ratio x-0.5516.1 -0.1%  
P/CF ratio (eoy) x-1.311.8 -10.7%  
Price / Book Value ratio x0.10.6 20.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8622,477 75.1%   
No. of employees `0001.4NA-   
Total wages/salary Rs m54756 976.4%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,1814,211 170.5%  
Other income Rs m4379 54.1%   
Total revenues Rs m7,2234,289 168.4%   
Gross profit Rs m947569 166.5%  
Depreciation Rs m2,543204 1,244.2%   
Interest Rs m4,377430 1,017.5%   
Profit before tax Rs m-5,93113 -46,699.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9246 -31,545.9%   
Profit after tax Rs m-4,0075 -83,468.8%  
Gross profit margin %13.213.5 97.6%  
Effective tax rate %32.448.0 67.6%   
Net profit margin %-55.80.1 -48,943.0%  
BALANCE SHEET DATA
Current assets Rs m14,3356,852 209.2%   
Current liabilities Rs m49,8096,711 742.2%   
Net working cap to sales %-494.03.3 -14,752.4%  
Current ratio x0.31.0 28.2%  
Inventory Days Days403161 250.8%  
Debtors Days Days171318 53.6%  
Net fixed assets Rs m55,4323,673 1,509.2%   
Share capital Rs m268317 84.6%   
"Free" reserves Rs m13,9353,761 370.5%   
Net worth Rs m14,7014,078 360.5%   
Long term debt Rs m9,4781,671 567.3%   
Total assets Rs m73,98812,633 585.7%  
Interest coverage x-0.41.0 -34.5%   
Debt to equity ratio x0.60.4 157.3%  
Sales to assets ratio x0.10.3 29.1%   
Return on assets %0.53.4 14.5%  
Return on equity %-27.30.1 -23,150.7%  
Return on capital %-6.47.7 -83.7%  
Exports to sales %25.922.9 113.1%   
Imports to sales %0.214.3 1.2%   
Exports (fob) Rs m1,860964 192.9%   
Imports (cif) Rs m12602 2.0%   
Fx inflow Rs m1,860964 192.9%   
Fx outflow Rs m25607 4.1%   
Net fx Rs m1,835357 514.1%   
CASH FLOW
From Operations Rs m1,7191,345 127.8%  
From Investments Rs m-3,148-2,256 139.6%  
From Financial Activity Rs m1,426-1,200 -118.9%  
Net Cashflow Rs m-3-2,111 0.2%  

Share Holding

Indian Promoters % 33.9 4.5 748.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 9.9 1.4 733.3%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 94.1 41.8%  
Shareholders   21,482 20,807 103.2%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS